We are live on ! Find out more
BBH icon

VanEck Biotech ETF

79 hedge funds and large institutions have $161M invested in VanEck Biotech ETF in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more call options, than puts

Call options by funds: $6.2M | Put options by funds: $1.18M

88% more capital invested

Capital invested by funds: $85.6M → $161M (+$75.5M)

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

10.85% more ownership

Funds ownership: 15.56%26.4% (+11%)

1% more funds holding

Funds holding: 7879 (+1)

4% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 25

Holders
79
Holders Change
+1
Holders Change %
+1.28%
% of All Funds
2.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
26
Reduced
25
Closed
5
Calls
$6.2M
Puts
$1.18M
Net Calls
+$5.01M
Net Calls Change
-$177K
Name Holding Trade Value Shares
Change
Change in
Stake
M
76
MOTCO
Texas
$12K
ASN
77
Advisory Services Network
Georgia
$8K +$8.09K +71 New
MFW
78
Mosaic Family Wealth
Missouri
$1K -$114 -1 -8%
VF
79
Virtu Financial
New York
-$3.38M -32,958 Closed
VKH
80
Virtu KCG Holdings
New York
-$676K -6,610 Closed
HF
81
HRT Financial
New York
-$462K -4,510 Closed
NPC
82
National Planning Corporation
California
-$454K -3,864 Closed
CCT
83
Country Club Trust
Missouri
-$340K -3,320 Closed

BBH Hedge Fund Activity: Q3 2016 in Review

79 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2016, worth a combined $161M — up 88% from $85.6M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new BBH positions and 5 closed out — a net gain of 2 holders — while 26 added to existing stakes and 25 trimmed.

The largest buyer was AllianceBernstein, opening a new position worth an estimated $68.1M. The largest seller was Virtu Financial, exiting entirely with an estimated $3.38M sold.

  • 79 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2016, up from 78 in Q2 2016.
  • Funds reported $161M of VanEck Biotech ETF stock for Q3 2016, up 88% quarter-over-quarter.
  • 7 funds opened new VanEck Biotech ETF positions in Q3 2016 and 5 closed out, a net change of +2 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2016 was AllianceBernstein, an estimated $68.1M added.
  • The largest VanEck Biotech ETF seller in Q3 2016 was Virtu Financial, an estimated $3.38M sold.

Based on aggregated 13F filings for Q3 2016.